Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus ropivacaine cocktail for postoperative analgesia after posterior cervical open-door laminoplasty
ChiCTR2400089274Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of liposomal bupivacaine, ropivacaine, epinephrine and dexamethasone in cervical osteoarthritis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Postoperative remedial morphine hydrochloride dose, Time to first postoperative remedial analgesia and 1 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacaineropivacaineepinephrinedexamethasone
03
Conditions
cervical osteoarthritis
Beyond the preview
Go deeper on ChiCTR2400089274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089274.